Matthew Sykes
Stock Analyst at Goldman Sachs
(3.89)
# 805
Out of 4,502 analysts
156
Total ratings
57.14%
Success rate
6.96%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Neutral | $225 → $250 | $270.09 | -7.44% | 4 | Jul 24, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $32 | $31.93 | +0.22% | 10 | Jul 17, 2024 | |
| WGS GeneDx Holdings | Maintains: Neutral | $13 → $28 | $32.72 | -14.43% | 7 | Jul 17, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $88 → $75 | $48.36 | +55.09% | 6 | Jul 17, 2024 | |
| CDNA CareDx | Maintains: Buy | $14 → $16 | $18.87 | -15.21% | 7 | Jul 17, 2024 | |
| TWST Twist Bioscience | Maintains: Buy | $45 → $55 | $57.51 | -4.36% | 9 | Jul 9, 2024 | |
| OMIC Singular Genomics Systems | Maintains: Neutral | $23 → $6.5 | $8.20 | -20.73% | 11 | Jul 9, 2024 | |
| QTRX Quanterix | Maintains: Buy | $35 → $24 | $15.27 | +57.17% | 13 | Jul 9, 2024 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,150 → $1,300 | $1,411.00 | -7.87% | 5 | Jul 9, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $7 | $8.51 | -17.74% | 7 | Jul 9, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.8 → $0.3 | $0.34 | -10.87% | 6 | Jul 9, 2024 | |
| BRKR Bruker | Maintains: Sell | $72 → $60 | $64.23 | -6.59% | 3 | Jul 9, 2024 | |
| TXG 10x Genomics | Maintains: Sell | $26 → $16 | $19.92 | -19.68% | 5 | Jul 9, 2024 | |
| FTRE Fortrea Holdings | Initiates: Neutral | $28 | $26.22 | +6.79% | 1 | Jun 6, 2024 | |
| IQV IQVIA Holdings | Initiates: Buy | $270 | $232.29 | +16.23% | 1 | Jun 6, 2024 | |
| ICLR ICON PLC | Initiates: Buy | $370 | $313.10 | +18.17% | 1 | Jun 6, 2024 | |
| CRL Charles River Laboratories International | Initiates: Buy | $290 | $221.81 | +30.74% | 1 | Jun 6, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $7 → $2.5 | $1.91 | +31.23% | 3 | Apr 19, 2024 | |
| VCYT Veracyte | Maintains: Buy | $32 → $28 | $23.76 | +17.85% | 3 | Apr 15, 2024 | |
| NTRA Natera | Maintains: Buy | $90 → $100 | $102.15 | -2.10% | 11 | Apr 15, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $550 → $640 | $594.50 | +7.65% | 3 | Apr 10, 2024 | |
| CTKB Cytek Biosciences | Maintains: Buy | $9 → $10 | $6.50 | +53.85% | 8 | Feb 29, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $17 → $19 | $15.08 | +25.99% | 5 | Feb 22, 2024 | |
| MYGN Myriad Genetics | Maintains: Buy | $28 → $31 | $27.85 | +11.31% | 9 | Jan 30, 2024 | |
| AVTR Avantor | Maintains: Buy | $23 → $26 | $22.82 | +13.94% | 4 | Dec 7, 2023 | |
| A Agilent Technologies | Maintains: Buy | $128 → $145 | $134.98 | +7.42% | 4 | Dec 7, 2023 | |
| QGEN Qiagen | Upgrades: Buy | n/a | $42.24 | - | 4 | Dec 7, 2023 | |
| RVTY Revvity | Maintains: Buy | $120 → $105 | $112.81 | -6.92% | 1 | Oct 31, 2023 | |
| NAUT Nautilus Biotechnology | Maintains: Neutral | $4 → $2 | $2.88 | -30.56% | 4 | Aug 3, 2022 |
Danaher
Jul 24, 2024
Maintains: Neutral
Price Target: $225 → $250
Current: $270.09
Upside: -7.44%
Guardant Health
Jul 17, 2024
Maintains: Buy
Price Target: $28 → $32
Current: $31.93
Upside: +0.22%
GeneDx Holdings
Jul 17, 2024
Maintains: Neutral
Price Target: $13 → $28
Current: $32.72
Upside: -14.43%
Exact Sciences
Jul 17, 2024
Maintains: Buy
Price Target: $88 → $75
Current: $48.36
Upside: +55.09%
CareDx
Jul 17, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $18.87
Upside: -15.21%
Twist Bioscience
Jul 9, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $57.51
Upside: -4.36%
Singular Genomics Systems
Jul 9, 2024
Maintains: Neutral
Price Target: $23 → $6.5
Current: $8.20
Upside: -20.73%
Quanterix
Jul 9, 2024
Maintains: Buy
Price Target: $35 → $24
Current: $15.27
Upside: +57.17%
Mettler-Toledo International
Jul 9, 2024
Maintains: Neutral
Price Target: $1,150 → $1,300
Current: $1,411.00
Upside: -7.87%
Maravai LifeSciences Holdings
Jul 9, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $8.51
Upside: -17.74%
Ginkgo Bioworks Holdings
Jul 9, 2024
Maintains: Sell
Price Target: $0.8 → $0.3
Current: $0.34
Upside: -10.87%
Bruker
Jul 9, 2024
Maintains: Sell
Price Target: $72 → $60
Current: $64.23
Upside: -6.59%
10x Genomics
Jul 9, 2024
Maintains: Sell
Price Target: $26 → $16
Current: $19.92
Upside: -19.68%
Fortrea Holdings
Jun 6, 2024
Initiates: Neutral
Price Target: $28
Current: $26.22
Upside: +6.79%
IQVIA Holdings
Jun 6, 2024
Initiates: Buy
Price Target: $270
Current: $232.29
Upside: +16.23%
ICON PLC
Jun 6, 2024
Initiates: Buy
Price Target: $370
Current: $313.10
Upside: +18.17%
Charles River Laboratories International
Jun 6, 2024
Initiates: Buy
Price Target: $290
Current: $221.81
Upside: +30.74%
Pacific Biosciences of California
Apr 19, 2024
Maintains: Neutral
Price Target: $7 → $2.5
Current: $1.91
Upside: +31.23%
Veracyte
Apr 15, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $23.76
Upside: +17.85%
Natera
Apr 15, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $102.15
Upside: -2.10%
Thermo Fisher
Apr 10, 2024
Maintains: Buy
Price Target: $550 → $640
Current: $594.50
Upside: +7.65%
Cytek Biosciences
Feb 29, 2024
Maintains: Buy
Price Target: $9 → $10
Current: $6.50
Upside: +53.85%
NeoGenomics
Feb 22, 2024
Maintains: Buy
Price Target: $17 → $19
Current: $15.08
Upside: +25.99%
Myriad Genetics
Jan 30, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $27.85
Upside: +11.31%
Avantor
Dec 7, 2023
Maintains: Buy
Price Target: $23 → $26
Current: $22.82
Upside: +13.94%
Agilent Technologies
Dec 7, 2023
Maintains: Buy
Price Target: $128 → $145
Current: $134.98
Upside: +7.42%
Qiagen
Dec 7, 2023
Upgrades: Buy
Price Target: n/a
Current: $42.24
Upside: -
Revvity
Oct 31, 2023
Maintains: Buy
Price Target: $120 → $105
Current: $112.81
Upside: -6.92%
Nautilus Biotechnology
Aug 3, 2022
Maintains: Neutral
Price Target: $4 → $2
Current: $2.88
Upside: -30.56%